A phase 1 trial of NBTXR3 nanoparticles activated by intensity-modulated radiation therapy (IMRT) in the treatment of advanced-stage head and neck squamous cell carcinoma (HNSCC).

被引：2
|
作者：
Le Tourneau, Christophe
Calugaru, Valentin
Jouffroy, Thomas
Rodriguez, Jose
Hoffmann, Caroline
Dodger, Bernard
Moreno, Victor
Calvo, Emiliano
机构：
[1] Inst Curie, Paris, France
[2] START Madrid, FJD, Madrid, Spain
[3] START Madrid, Ctr Integral Oncol Clara Campal, Madrid, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.6080
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6080
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Elderly patients with locally advanced head and neck squamous cell carcinoma treated with NBTXR3 nanoparticles activated by radiotherapy: A phase I trial
    Le Tourneau, C.
    Calugaru, V.
    Moreno, V.
    Mirabel, X.
    Dodger, B.
    Calvo, E.
    Jouffroy, T.
    Rodriguez, J.
    Chilles, A.
    Yemi, M.
    Hoffmann, C.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [2] Phase I dose-escalation study of NBTXR3 activated by intensity-modulated radiation therapy in elderly patients with locally advanced squamous cell carcinoma of the oral cavity or oropharynx
    Hoffmann, Caroline
    Calugaru, Valentin
    Borcoman, Edith
    Moreno, Victor
    Calvo, Emiliano
    Liem, Xavier
    Salas, Sebastien
    Doger, Bernard
    Jouffroy, Thomas
    Mirabel, Xavier
    Rodriguez, Jose
    Chilles, Anne
    Bernois, Katell
    Dimitriu, Mikaela
    Fakhry, Nicolas
    Kam, Stephanie Wong Hee
    Le Tourneau, Christophe
    [J]. EUROPEAN JOURNAL OF CANCER, 2021, 146 : 135 - 144
  • [3] Update of Phase I/II Accelerated Intensity-modulated Radiation Therapy for Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
    Song, S.
    Johnson, C. J.
    Gurka, M. K.
    DiNardo, L. J.
    Reiter, E. R.
    Dogan, N.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S386 - S387
  • [4] Phase I trial of cetuximab, intensity modulated radiotherapy (IMRT), and ipilimumab in previously untreated, locally advanced head and neck squamous cell carcinoma (PULA HNSCC)
    Ferris, R. L.
    Clump, D. A.
    Ohr, J.
    Gooding, W.
    Kim, S.
    Karlovits, B. J.
    Duvvuri, U.
    Johnson, J. T.
    Petro, D.
    Heron, D. E.
    Bauman, J.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [5] Phase I trial of cetuximab, intensity modulated radiotherapy (IMRT), and ipilimumab in previously untreated, locally advanced head and neck squamous cell carcinoma (PULA HNSCC)
    Bauman, J.
    Ferris, R. L.
    Clump, D. A.
    Ohr, J.
    Gooding, W.
    Kim, S.
    Karlovits, B.
    Duvvuri, U.
    Johnson, J. T.
    Petro, D.
    Heron, D.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [6] Phase III randomized trial of intensity-modulated proton therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for the treatment of head and neck oropharyngeal carcinoma (OPC).
    Frank, Steven J.
    Busse, Paul
    Rosenthal, David Ira
    Hernandez, Mike
    Swanson, David Michael
    Garden, Adam S.
    Sturgis, Erich M.
    Ferrarotto, Renata
    Gunn, Gary Brandon
    Patel, Samir H.
    Lee, Nancy Y.
    Lin, Alexander
    Snider, James W.
    McDonald, Mark William
    Henson, Christina
    Bajaj, Gopal Krishna
    Kalman, Noah
    Parvathaneni, Upendra
    Katz, Sanford R.
    Foote, Robert Leonard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] Phase II study of bevacizumab (B) plus cisplatin (C) plus intensity-modulated radiation therapy (IMRT) for locoregionally advanced head and neck squamous cell cancer (HNSCC): Preliminary results
    Pfister, D. G.
    Lee, N. Y.
    Sherman, E.
    Lisa, D.
    Carlson, D.
    Stambuk, H.
    Shen, R.
    Kraus, D.
    Shah, J.
    Fury, M. G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [8] Phase I study of weekly nab-paclitaxel plus weekly cetuximab plus intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC)
    Fury, M. G.
    Sherman, E. J.
    Rao, S. S.
    Wolden, S.
    Smith-Marrone, S.
    Mueller, B.
    Ng, K. K.
    Dutta, P. R.
    Gelblum, D. Y.
    Lee, J. L.
    Shen, R.
    Kurz, S.
    Katabi, N.
    Haque, S.
    Lee, N. Y.
    Pfister, D. G.
    [J]. ANNALS OF ONCOLOGY, 2014, 25 (03) : 689 - 694
  • [9] Comparing the oncologic outcomes of proton therapy and intensity-modulated radiation therapy for head and neck squamous cell carcinoma
    Chang, Chia-Lun
    Lin, Kuan-Chou
    Chen, Wan-Ming
    Shia, Ben-Chang
    Wu, Szu-Yuan
    [J]. RADIOTHERAPY AND ONCOLOGY, 2024, 190
  • [10] Intensity-modulated proton therapy (IMPT) versus intensity-modulated radiation therapy (IMRT) for the treatment of head and neck cancer: A dosimetric comparison
    Nguyen, My-Lien
    Cantrell, J. Nathan
    Ahmad, Salahuddin
    Henson, Christina
    [J]. MEDICAL DOSIMETRY, 2021, 46 (03) : 259 - 263
12345